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The role of antibody in the regulation of the immune response has become 
a  major issue only in the past few years, even though it has been known for 
over half a century that mixing antigen with excess antibody can suppress the 
antibody response (1). A regulatory role of antibody in the immune response 
was first suggested by Uhr and Baumann  (2)  in  1961,  based on experiments 
showing that passive antibody inhibits the immune response. Although it has 
clearly been  demonstrated by numerous workers  (cited in reference 1)  that 
passive  antibody can  interfere with  the  expression of an  immune  response, 
little information has been obtained which demonstrates the role of antibody 
produced during an antibody response on the control of that same response. 
The best evidence supporting the latter point is  the enhancement of the  im- 
mune response after removal  of circulating antibody (3, 4).  Such information 
strongly suggests that circulating antibody plays an important role in regula- 
tion of the immune response once it has been initiated. In the case of antigens 
which  persist  in  the  body  tissues,  antibody may also  regulate  the  immune 
response over longer periods of time.  In fact, it has been demonstrated that 
the  immune  response  to  lipopolysaccharide  from  Escherichia  coli  shows  a 
cycling phenomenon which appears to be controlled by the level of circulating 
antibody  (5).  Thus,  while both normal  catabolism of antigen and inhibition 
by antibody may terminate the immune response to antigens that are readily 
catabolized,  it  appears  that  antibody alone  is  probably responsible  for  the 
regulation  of  the  immune  response  to  antigens  such  as  lipopolysaccharides 
which are poorly catabolized and persist in tissues for long periods of time. 
The present  paper  shows  that  injection of the  aggregated  form of serum 
protein antigens in rabbits results in a cyclic appearance of antibody-producing 
cells which appears to be synchronized. Experiments will  be presented which 
both implicate locally produced antibody in regulation and delineate some of 
the possible cellular events that may be involved. 
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Materials and Methods 
Animals.--New Zealand White rabbits weighing 2.5-3.0 kg were used in all experiments. 
Antigens.--Cohn  fraction II from human sera (HGG) 1 was obtained through the courtesy 
of the American Red Cross National Fractionation Center. The IgG fraction (HuIgG) was 
isolated by  diethylaminoethyl  (DEAE)-cellulose chromatography  on  columns  equilibrated 
with 0.01  M  phosphate buffer,  pH  8.0.  Pooled  turkey sera was  precipitated  (twice)  with 
ammonium sulfate [(NH4)2SO4] at a final concentration of 35% and the IgG fraction (TuIgG) 
was isolated by filtration on G-200 Sephadex essentially according to the method described 
by Benedict (6). Both immunog]obulins were heat aggregated at 63°C for 25 rain (7). 
Radioisotope Studies.--Proteins  were trace labeled by the chloramine-T method as modified 
by McConahey and Dixon (8). Radioactivity was measured in a gamma scintillation counter 
with a sodium iodide crystal. 
X  Radiation.--Two  opposing 220 kV Picker machines, 160 cm apart, were used to deliver 
500 R  whole body irradiation (50-55 R/min) to rabbits placed in a leucite container midway 
between the sources. The machines were operated at 210 kV,  15 mA, with an inherent filter 
of 0.25 mm Cu and 1 mm A1. 
Hemolytic Plaque Assay.--Spleens  and mesenteric lymph nodes were removed from rabbits 
immediately after exsanguination, trimmed of fat, and teased apart in balanced salt solution 
(BSS) buffered to pH 7.0 with ethylenediaminetetraacetic acid (EDTA) at a final concentra- 
tion of 0.02 M.  Spleen fragments were teased through 90-mesh wire screens  (Newark Wire 
Cloth Co.,  Newark,  N.  J.)  and  filtered through nylon monofilament cloth  (Tobler, Ernst, 
Traber, Inc., New York). Cells were washed one time in EDTA-BSS and three times in BSS 
(all centrifugations at 250 g for 10 rain at 4°C) before suspending to a concentration of 2-4 X  10  ~ 
cells/ml. 
Blood was collected sterilely by cardiac puncture into tubes containing EDTA, penicillin, 
and streptomycin at final concentrations of 0.02  M,  100 U/ml and 100 #g/ml, respectively. 
The blood was mixed in a graduated cylinder with an equal volume of 3% gelatin (Matheson, 
Coleman and Bell, Los Angeles, Calif.)  dissolved in EDTA-BSS.  The cells were allowed to 
settle 30 rain at 37°C, and the supernate was aspirated as closely as possible to the red blood 
cell interface. The supernate was centrifuged at 250 g for 10 min at 37°C, washed one time in 
EDTA-BSS also at 37°C, and treated with 10 ml 0.83% ammonium chloride for 5 rain at room 
temperature (to lyse contaminating red blood cells)  before centrifugation at 4°C.  Ceils were 
washed three times in BSS and suspended to a concentration of 2-4 X  107 cells/ml. All proce- 
dures for isolating cells from blood were carried out with siliconized glassware. 
Antibody-forming cells were measured by a modification (9) of the Jerne plaque assay (10). 
Goat red blood cells (GRBC)  (Colorado Serum Co., Denver, Colo.) were used as indicator 
cells.  GRBC-absorbed HGG or GRBC-absorbed turkey gamma globulin, prepared by 2X 
precipitation of turkey sera with 35% (NH4)2SO4, were covalenfly bound to the GRBC with 
1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide HC1 (Ott Chemical Co., Muskegon, Mich.). 
Conjugated GRBC and appropriate dilutions of either spleen, lymph node, or blood cells were 
added to 0.5 ml of 0.5% agarose (L'Industrie Biologique Francaise, Gennevilliers, France) at 
45°C,  and  the suspension  was  immediately plated  on  microscope  slides which were  then 
incubated in a  humidifying chamber for 1 h  at 37°C.  Plaque-forming cells (PFC)  were de- 
veloped by inverting the slides for 21~ h  in complement (1:10 dilution of guinea pig sera in 
BSS), either with amplifying antibody (sheep anti-rabbit IgG at an optimal dilution of 1 : 100) 
(indirect PFC), or without amplification (direct PFC).  For differentiation of IgM- and IgG- 
PFC,  slides were first immersed in 0.005  M  dithiothreitol (DTT)  (Calbiochem, San Diego, 
1  Abbreviations used in this paper: BSS, balanced salt solution; DTT, dithiothreitol; GRBC, 
goat red blood cells;  HGG,  Cohn fraction II from human sera; IA, iodoacetamide; PFC, 
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Calif.) diluted in pH 8.6 Tris-NaC1 buffer (0.15 M), followed by immersion in 0.011 M iodo- 
acetamide (IA) (three times recrystallized)  (K & K Laboratories, Plainview, N. Y.) diluted 
in pH 7.3 Tris-NaC1, and three washes in BSS at 4°C (11). 
Hyperimmune Cells.--Hyperimmune cells were obtained by giving rabbits five daily sub- 
cutaneous injections of antigen (8 mg soluble HGG and 2 mg aggregated HuIgG). After 2 wk, 
the rabbits were given a second series of injections of antigen  (13 mg soluble HGG and 2 
mg aggregated HulgG) subcutaneously daily for 4 days, with 30 mg/kg body weight given 
intravenously  on the 5th day. Additional courses of 15 mg antigen were given to some animals 
1 mo or more after the last course. Animals were bled 7 days after the last injection and in- 
dividual sera were tested for precipitating  antibody.  The average antibody titer of donors 
used in each experiment ranged from 170 to 850/zg antibody N/ml. Cells were used in transfer 
experiments 3-7 wk after  the last injection. Spleen ceils and mesenteric lymph nodes were 
removed immediately after exsanguination, trimmed of fat,  and teased apart in Auto-Pow 
minimal essential media  (Flow Laboratories,  Inglewood, Calif.) containing  1.7  mg sodium 
bicarbonate, 100 #g streptomycin, and 100 U penicillin per ml. Cell suspensions were filtered 
as described previously, centrifuged at 250 g, and resuspended to the desired concentration. 
Measurement of [125I]HulgG  in Tissues.--HulgG was radiolabeled with 1251 and aggregated, 
and 2 mg (52/zCi/mg) was injected intravenously into rabbits. The animals were exsanguinated 
2 or 10 days later, and sections of various tissues were immediately removed and dissected 
free of gross fat and blood clots. Thin sections were prepared for autoradiography and processed 
with NTB-2 Nuclear Track Emulsion (Eastman Kodak, Rochester, N~ Y.). Slides were de- 
veloped after  14 days and stained  with  hematoxylin. The remaining tissue  sections were 
weighed, teased apart in saline, and counted in a gamma scintillation counter with a NaI 
crystal.  Tissues were then sonicated in a 250 W,  10 kcycle Raytheon  Sonic Oscillator and 
counted for 125I activity before and after precipitation with an equal volume of 20% trichloro- 
:acetic acid (TCA). All procedures up to TCA precipitation were carried out at 4°C. The TCA 
precipitates were centrifuged at 1100 g for 15 rain and washed threetimes in 10% TCA before 
counting. 
Antibody Analyses.--The  levels of precipitating  antibody to HuIgG were measured by a 
quantitative precipitation technique (12) and calculated on the basis of a ratio of antibody 
to antigen nitrogen of 2.5. 
RESULTS 
Cyclical Appearance of yPFC after a Single Injection of Antigen.--The  splenic 
PFC response to a  single intravenous injection of 2 mg aggregated HulgG is 
shown in Fig. 1, which gives the average PFC from spleens of 5-20 rabbits on 
each day.  PFC were first detected 3  days after injection and reached a  peak 
on day 5. The number of PFC then decreased rapidly, with less than 20% of 
the peak number remaining on day 6. The number of PFC remained at a  low 
level until day 12, at which time there was a significant increase. A second peak 
of PFC occurred on day 13, 8 days after the first peak, and was comparable to 
the level of the day 5 peak. 8 days later (21 days after injection) a  third peak 
of PFC was detected, although not as high as the preceding peaks. Both direct 
and indirect PFC followed this pattern. 
A similar type of response was seen in the spleen after a single intravenous in- 
jection of 2 mg aggregated TulgG (Fig. 2). Indirect PFC reached a peak 4a/~ 
days after injection, decreased,  and peaked a  second time on day 12.  In this 
case, the interval between peaks was again approximately 8 days. Direct PFC CAROLE  G.  ROMBALL  AND  WILLIAM  O.  WEIGLE  1429 
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FIG.  1.  Kinetics of the appearance of PFC in spleens of rabbits after a  single intravenous 
injection of 2 mg aggregated HuIgG. 
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FIG.  2.  Kinetics of the appearance of PFC in spleens of rabbits after a  single intravenous 
injection of 2 mg aggregated TuIgG. 
were only 13 % of the indirect PFC on day 4]/~ and were not detected on day 12, 
possibly because the plaque technique was not sensitive enough to detect the 
small number that would have been expected. On day 12,  the indirect PFC 
were only 40% of the initial peak. The rapid disappearance of PFC after the 
day 5 peak was specific  since the response to an injection of 2 mg of TulgG 
was not affected by an injection of 2 mg of HuIgG given 4]/~ days previously. 
Correlation  of Direct and Indirect PFC with 19S and 7S A ntibody-Producing 
Cells.--Reduction  and alkylation of antibody produced by PFC  (with DTT 
and IA,  respectively) before addition of complement was used to determine 
the class  of antibody to HulgG secreted from spleen cells of rabbits injected 
with 2 mg of aggregated HuIgG. Direct PFC were inhibited at least 95 % in 
both primary (day 5) and secondary responses (day 6), whereas indirect t>FC 
were inhibited only 7 % (Table I). Therefore, the sheep antirabbit IgG used as 
amplifying antibody would appear to be capable of both enhancing IgG PFC 1430  CYCLICAL  APPEARANCE OF  ANTIBODY-PRODUCING CELLS 
and inhibiting IgM  PFC.  Treatment  with IA alone had  no  significant effect 
on PFC. 
Secondary PFC Response.--The  splenic PFC response in primed rabbits (in- 
jected with 2 mg aggregated HulgG 40--85 days before the second injection) re- 
presented a typical secondary response (Fig. 3). On day 2, the 1st day tested, there 
were already significant numbers of PFC, whereas PFC could not be detected 
until day 3 of the primary response. The peak PFC occurred on day 3 instead 
of day 5  (as  shown  in  an  experiment where  indirect PFC  in  the peripheral 
blood on  days 2,  3,  and  4  after a  second injection of antigen  averaged 249, 
3,923,  and  452  PFC/106  cells,  respectively,  whereas  the  primary  response 
TABLE I 
Effect of Reduction and Alkylation  on PFC to HulgG* 
Treatment 
Primary response  Secondary response 
Direct  Indirect  Direct  Indirect 
None  26  301  546  3083 
DTT +  IA  0  (100%)~  298  (0%)  30  (95%)  2862  (7%) 
In  22  (14%)  303  (0%)  561  (0%)  3054  (0%) 
DTT  =  dithiothreitol; IA =  iodoacetamide. 
* Per 106 spleen cells. 
The figures in parentheses represent the percent reduction in PFC of treated  cells  as 
compared with cells receiving no treatment. 
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FzG. 3.  Kinetics of the appearance of PFC in spleens of rabbits after a second injection of 
2 mg aggregated HulgG. All rabbits were injected intravenously with a primary dose of 2 
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occurred on day 5 in both the spleen and blood). Also,  the magnitude of the 
peak secondary response was approximately 10-fold greater than that of the 
primary response.  No  additional significant peaks  of direct or indirect PFC 
were detected even though PFC were measured on day 6 and daily from days 
8 to  16. Again, both indirect and direct PFC followed the same kinetics, al- 
though direct PFC were less  than 20 %  of the indirect PFC. As each point 
represents the average PFC from only three rabbits,  the minor variations in 
numbers of PFC that occurred were probably the result of animal variability. 
Comparison of Spleen and Mesenteric Nodes.--Indirect PFC in the mesenteric 
lymph nodes were measured on days 5,  8,  and  13 after a  single intravenous 
injection of 2 mg aggregated HuIgG and compared with indirect PFC in the 
spleens of the same rabbits  (Table II). The results, representing the average 
PFC per 106 node or spleen cells of five rabbits for each day, show that PFC 
per  106 cells in the nodes were approximately 50% of those in the spleen on 
TABLE  II 
Appearance  of PFC in Spleens  and  Mesenteric  Lymph  Nodes  of Rabbits  after a  Single 
Intravenous Injection of 2 mg Aggregated ttulgG 
Indirect PFC/106 Cells* 
Organ 
Day 5  Day 8  Day 13 
Spleen  160.8  4.1  119.1 
Nodes  75.5  9.0  11.5 
*Values represent average of five rabbits for each day. 
day 5. By day 8, PFC in the nodes had decreased almost to background levels 
and, in contrast to splenic PFC, did not peak again on day 13. 
Tissue Localization  of HulgG.--Rabbits  were injected intravenously with 2 
mg aggregated [125I]HuIgG and exsanguinated on either day 2 or day 10. Lung, 
kidney, liver, spleen, mesenteric lymph node, and thymus (day 10 only) sec- 
tions were taken for histological examination and for radioactivity measure- 
ments. Less than 5 %  of the injected radioactivity could be detected in the 
blood within 10 rain after injection of the antigen. 2 days after injection, counts 
of sonicated tissues showed that lungs retained the greatest amount of TCA- 
precipitable radioactivity per gram of tissue (9.8 ~g [125I]HulgG/g tissue) and 
spleens retained the next highest amount (1.14/zg  [125I]HuIgG/g tissue) (Table 
III).  By day 10,  the amount of antigen retained had decreased by approxi- 
mately 90 % in all tissues (giving a half-life of approximately 2.5 days) except 
the spleen. In contrast, the half-life of [l~SI]HuIgG in the spleen was 12.8 days. 
Autoradiographs of spleen and lymph node sections on day 2 showed diffuse 
label throughout the follicles, whereas by day 10, label was concentrated in the 
germinal centers of the spleen,  and no label could be detected in similar areas 
of the nodes (Fig. 4). 1432  CYCLICAL  APPEARANCE OF ANTIBODY-PRODUCING CELLS 
Persistence of Immunogenicity  of Injected HulgG.--Irradiated  rabbits injected 
with 2 nag aggregated HulgG 24 h  after irradiation (500 R) were injected with 
1.8-2.1  X  109 sensitized cells at various times after receiving the antigen. Cell 
suspensions were prepared from spleens and mesenteric lymph nodes of hyper- 
immune animals and injected (without antigen) in approximately equal propor- 
tions,  spleen  cells  intravenously and  node  cells  intravenously and  intra- 
peritoneally. Spleens of the recipients were plaqued 31/~ days after injection of 
hyperimmune cells. The number of indirect PFC was calculated as  a  percent 
TABLE III 
Organ Distribution  of Aggregated [125I]HuIgG (2 rag) in Rabbits after Intravenous  Injection 
on Day 0 
gg[t2~I]-HulgG/g tissue 
Organ  Day 2  Day 10  t*/2 (days)$ 
Total  TCA-ppt*  Total  TCA-ppt 
Lung  10.62  9.8  0.91  0.86  2.3 
Kidney  0.63  0.26  0.03  0.02  2.5 
Liver  0.25  0.15  0.02  0.02  2.7 
Spleen  1.36  1.14  0.79  0.74  12.8 
Mesenteric  0.17  0.09  0.01  0.01  2.5 
lymph nodes 
Thymus  --  --  0.01  0.01  -- 
Values represent averages of three animals for each day. 
* Trichloroacetic acid precipitable. 
:~ The tl/2 value was calculated between day 2 and day 10 and was based on TCA-precipi- 
table activity. 
FIG. 4.  Autoradiographic evidence of follicular localization of [l~5I]HulgG  in the spleens 
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of indirect  PFC  in irradiated  recipients receiving 2 mg aggregated HulgG at 
the time of injection of sensitized  cells.  Rabbits receiving antigen  24 h  after 
irradiation  and not receiving sensitized cells showed essentially no PFC when 
plaqued  at the same time.  Based on the above criteria,  52 %  of the injected 
aggregated HulgG remained in an immunogenic form in rabbits injected with 
antigen 10 days earlier (Fig. 5). By days 20 and 30, the effective concentration 
decreased  to  12 %  and  3 %,  respectively.  At  days  60 and  90,  essentially  no 
"immunogenicity" remained. 
Effect  of Dose of Antigen on Kinetics of PFC.--Rabbits were injected with 
0.02, 0.2, 2.0, or 20 mg aggregated HuIgG intravenously and spleens from each 
group were plaqued 4, 5, 6, 8, 12, 13, or 14 days after injection. With each dose 
of antigen,  two peaks of PFC were detected (Fig. 6). In this single experiment, 
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FIG.  5.  Persistence of HuIgG in irradiated rabbits as measured by its in vivo ability to 
stimulate sensitized donor cells.  Recipient rabbits received 500 R whole-body irradiation 24 h 
before an intravenous injection of 2 mg aggregated HulgG. For all days except day 10, an 
additional 500 R  was given 24 h  before injections of sensitized cells on the days indicated. 
Splenic PFC  were  assayed 41~  days  after injection of  sensitized cells  and expressed as a 
percentage of the response of irradiated rabbits injected with both sensitized cells and 2 mg 
aggregated HulgG. 
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FIG. 6.  Kinetics of the appearance of indirect PFC in spleens of rabbits after a single intra- 
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the PFC to 2.0 mg aggregated HuIgG peaked on day 4 and the PFC to 0.02 
mg aggregated HuIgG peaked day 6, while the PFC in rabbits injected with 
the other two doses peaked at the usual time, on day 5. Also,  animals injected 
with 20 rag aggregated HulgG showed a  second peak later than day 13. The 
variability in time of appearance of peak PFC may reflect a true variability in 
the kinetic pattern among different rabbits. More likely, the variability is the 
result of the small number of animals used and the quantitative differences in 
PFC among different rabbits. In any event, with all doses, two peaks of PFC 
could be detected and were separated  by approximately 8 days of markedly 
decreased responsiveness.  The height  of the  second peak  obtained with  the 
various doses was inversely proportional to the height of the first peak and to 
the dose of antigen injected. 
Kinetics of PFC in Spleen vs. Peripheral Blood.--The kinetics of the PFC re- 
sponse in the peripheral blood were essentially identical with that in the spleen 
as can be seen in Fig. 7, which shows the average PFC responses of four rabbits 
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FIG. 7.  Kinetics of the appearance of PFC in spleens and peripheral blood of rabbits after 
a single intravenous injection of 0.2 mg aggregated HulgG. 
after injection of a  single dose of 0.2  mg aggregated HuIgG. If there is a  lag 
between appearance of PFC in the spleen and in the blood, it is less than 24 h 
as can be seen by comparing the PFC responses on days 12, 13, and 14. 
Appearance  of Precipitating  Antibody  in Relation  to Appearance  of PFC.-- 
Spleens of rabbits were plaqued after intravenous injection of 2 mg aggregated 
HuIgG  and  sera  from  these  rabbits  analyzed  for  precipitating  antibody. 
Precipitating antibody was too low to be detected until day 5  (the peak day 
for PFC)  but rose to a peak on day 8  (Fig. 8). The antibody level decreased 
rapidly until after the second peak, when it rose again. When individual rabbits 
were analyzed (on days 5, 8, 13,  16, and 21 after injection of antigen) for PFC 
in their peripheral blood and precipitating antibody in their sera, the depend- 
ence of antibody on PFC can be seen clearly (Fig. 9). After the first peak of PFC 
on day 5 for rabbit 1, antibody peaked on day 8, then started to decrease until 
the second peak of PFC appeared on day 13. The serum antibody level then 
remained at a high level. In rabbit 2, no second peak of PFC occurred and anti- 
body levels in the serum showed a continued decrease after peaking on day 8. CAROLE  G.  ROMBALL  AND  WILLIAM  O.  WEIGLE  1435 
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FIG.  8.  Relationship  between PFC in spleens of rabbits  and precipitating  antibody in 
peripheral blood after a single injection of 2 mg aggregated HuIgG. 
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Fro. 9.  Relationship between :PFC and precipitating  antibody in peripheral blood after a 
single intravenous  injection  of 2 mg aggregated HuIgG. The data are from representative 
rabbits which were bled 25 ml of blood (cardiac) on the respective days. 
DISCUSSION 
The  above  data  suggest  that  a  specific  control  mechanism  regulates  the 
formation of antibody-producing cells to a  persisting antigen,  resulting in the 
cyclical production of PFC. PFC in the spleens of rabbits were shown to appear, 
disappear, and reappear after a single intravenous injection of either aggregated 
HuIgG or aggregated TuIgG. After an initial peak of PFC on day 5, two sub- 
sequent peaks of PFC were observed at 8-day intervals, with a marked decrease 
in the number of PFC detected during these intervals. The levels of precipitat- 
ing antibody in the serum reflected events occurring at the single cell level with 
a  delay of approximately 3 days, accounting for the period of time needed for 1436  CYCLICAL  APPEARANCE  OiF  ANTIBODY-PRODUCING  CELLS 
secretion and equilibration of antibody into the fluid spaces. Such fluctuations 
in PFC levels after a single injection of antigen have been described previously. 
Britton  and M611er (5)  showed cyclical peaks of PFC in mice injected intra- 
peritoneally with heat-killed Escherichia coll. Sell et al.  (13)  demonstrated two 
peaks of IgA-, -yl-, -r2a-, and ~,2b-producing PFC in the spleens of mice after a 
single intravenous  injection  of SRBC.  However,  only a  single peak of IgM- 
producing PFC was detected. 
The identical kinetics of IgM and IgG synthesis in rabbits immunized with 
aggregated  HuIgG indicates  that  if a  switch  from IgM  to  IgG production 
occurs, it takes place at a  stage in differentiation before the secretion of im- 
munoglobulins. Evidence for a  switch has been observed by several groups of 
workers. Lymphocytes in rabbits have been shown to have cell surface IgM  2 
while synthesizing IgG, suggesting that after triggering of the cell by antigen 
there is a point when the cell switches from the synthesis of IgM to the syn- 
thesis of IgG (14). In the rabbit, this switch may explain why, for many antigens, 
the dominant molecular class for B-cell receptors is IgM, while in the plasma 
cell and serum IgG predominates (15).  Pierce et al.  (16) provided further evi- 
dence of a switch mechanism by inhibiting in vitro the IgG and IgA responses 
to SRBC with incorporation of anti-/~-chain into the cultures. Furthermore, the 
first  appearance of IgG-PFC  to  SRBC  in  spleens of recipient  mice injected 
with SRBC and normal lymphocytes was associated  with  clones  of cells  pre- 
viously producing IgM (17-19). Other data are also available which indirectly 
support either an in vivo or in vitro switch in immunoglobulin class during dif- 
ferentiation  (20-23).  Direct  evidence for double producers  of IgG and  IgM 
has been reported by Nossal and coworkers (24,  25),  who were able to isolate 
cells containing both IgM and IgG. However, since only a few (1.5 %) double 
producers were detected,  it has been suggested that the majority of IgG-syn- 
thesizing cells could not have arisen from IgM producers (26-28). 
An interesting aspect of the present study is that the appearance of PFC after a 
single  intravenous injection  of  the  antigen  seems  to be synchronous.  Although  it 
appears most likely that  the apparent "synchrony" can be attributed  at least in- 
directly to antibody, the precise  mechanism is difiScult to understand.  It has often 
been demonstrated that passive antibody can interfere with the development of an 
immune response (cited  in reference  1). Britton and M611er (5) have suggested  that 
antibody  controls fluctuations  in  the  immune response  to  persisting  antigens.  In 
their experiments, a  cyclical  appearance of both antibody and PFC  occurred after 
injection of the lipopolysaccharide  of Escherichia toll,  although synchrony was not 
2 Monomeric IglY[ has been isolated and identified as the predominant immunoglobulin on 
the lymphocytes of mice (Vitetta, E. S., S. Baur, and J. w. Uhr. 1971. Cell surface immuno- 
globulin. II. Isolation and characterization of immunoglobulin from mouse splenic lympho- 
cytes. J. Exp. Med. 1B4:242; Kennel, S. J., and R. A. Lerner. 1973. Isolation and characteriza- 
tion of plasma membrane associated immunoglobulin from cultured human diploid lympho- 
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apparent. It has been proposed that the regulation of antibody production to both 
persisting and readily catabolizable antigens is controlled by antibody via a dynamic 
equilibrium  among  circulating antibody, antigen,  and  antigen-antibody complexes 
throughout the extracellular compartments (29).  It would be difficult to explain the 
synchrony observed in the present experiments by such a mechanism since the inter- 
val between the peaks was not affected by the serum level of the antibody either pro- 
duced or present at the time of appearance of the second PFC peak. However, the 
precise timing of peaks of PFC could be explained in part by antibody control if the 
regulating antibody was effective locally at the sites of production. The local concen- 
tration of antibody, in any given loci, would be the same in all animals, and it would 
be independent of  the total amount  in either the extra- or intravascular compart- 
ments. The latter possibility would explain the rapid decrease in PFC numbers which 
occurs regardless of the total antibody present in  the  serum.  In addition, another 
event must occur to account for both the reappearance of PFC at a precise time and 
the longer induction period. Such synchrony could be explained by control mecha- 
nisms that have been described in other systems. The available data suggest that the 
regulation of cell renewal can be achieved by extending or contracting the length of 
the G1 period (30, 31), and it appears that such regulation is tissue specific. In addi- 
tion, cells from a variety of organs can be stimulated to begin dividing again after a 
period in which DNA  synthesis had  been  arrested. From incorporation studies of 
cells blocked at different phases of the mitotic cycle, it has been determined that cells 
can enter mitosis upon an appropriate stimulus from G1, or less likely, directly from 
G2 (32).  Furthermore, a latent period has been observed when cells can not respond 
to a  stimulus by dividing (33).  In spleens of rabbits producing PFC to aggregated 
HuIgG,  inactivation of  antigen by  antibody produced locally could result in  cells 
being arrested in some phase of the cell cycle. Only cells developed beyond a certain 
point would continue to differentiate to PFC, while cells developed to a lesser degree 
would be blocked temporarily from further division and differentiation. Upon termi- 
nation of this latent period, cells would again be stimulated in the spleen by antigen 
uncovered when antibody diffused into the circulation. Thus, due to a transient cur- 
tailment of antigenic stimulation, cells that had not completed enough differentiation 
to become PFC without further antigenic stimulation may be arrested temporarily. 
When they are again capable of responding, antigen would be available in the spleen 
to restimulate them and synchronization of PFC could occur. In any event, it appears 
likely that the control of the latent periods and the synchrony of the appearance of 
PFC in the present system are exercised through some event(s) in the G1 period. In 
this case, the effect on G1 is probably the result of an indirect effect of antibody present 
at or near the site of its production. 
The  above  reasoning  would  imply  that  although  the  initial peak  of  PFC 
results from  the  stimulation of virgin precursor cells, succeeding peaks must 
be  the  result  of stimulation  of memory  cells. This  same  reasoning makes  it 
difficult to imagine a  mechanism for stimulation of virgin precursor cells over 
different periods of time that would result in such precise timing of peak PFC 
over a  1,000-fold range in the dose of antigen administered. Nor is it easy to 
visualize a  mechanism  that would result in the synchronized reappearance of 1438  CYCLICAL  APPEARANCE  OF  ANTIBODY-PRODUCING  CELLS 
PFC arising directly from virgin B  cells.  Also,  although the magnitude of the 
first peak of PFC varied directly with the dose of antigen administered,  the 
second peak was inversely related to dose, sugge3ting that with large amounts 
of antigen, more cells were stimulated directly to PFC, leaving fewer memory 
cells available for restimulation. In co atrast, with small amounts of antigen, cells 
were stimulated  to differentiate, yet with mgst cells not enough hits per cell 
occurred to complete the pxthway from precursor to PFC. This would explain 
why, after injection of extremely small amounts of antigen (0.02 mg), the second 
peak of PFC was gretter than the first peak. 
The cyclic appearance of peaks  of PFC  in the spleens of rabbits  after an 
intravenous injection of aggregated HuIgG apparently depends on the persist- 
ence of antigen in this organ. The preferential persistence of this antigen in the 
spleen was demonstrated both functionally and directly by determining organ 
distribution  of TCA-precipitable [l~SI]HuIgG  and  by autoradiography.  First, 
it was shown that sensitized cells could be specifically stimulated in irradiated 
recipients injected with aggregated HulgG at least 30 days before transfer of 
the cells.  Using similar cell transfer procedures, Britton et al.  (34) have shown 
the persistence of SRBC  for at  least  14 days  and  Escherichia  coli  lipopoly- 
saccharide for at least 45 days. Second, the injection of [125I]HuIgG resulted in 
localization of some antigen in most of the tissues tested; however, the major 
localization was in the lung and spleen as would be expected after an intra- 
venous injection. The labeled HuIgG was rapidly catabolized in the lungs and 
other tissues,  but persisted in the spleen with a  half-life of approximately 13 
days.  Autoradiography  showed  dense  localization of  the  [~2~I]HuIgG in  the 
germinal centers of the spleen 10 days after injection, while no such localization 
was  observed at  this  time in  the lymph  nodes. The failure to observe such 
localization in lymph nodes corresponds with the failure to observe a  second 
peak of PFC in lymph nodes on day 13. Localization of antigen after various 
routes of injections has been extensively studied and was reviewed by Nossal 
and coworkers (35,  36). In the present studies,  dense deposits of [125I]HuIgG 
were localized in the central areas of germinal centers of spleens,  but not in 
lymph nodes, 10 days after injection. It is not clear whether the dense localiza- 
tion in the germinal centers of the spleen was induced by antibody, as has been 
demonstrated with soluble antigens  (35, 37), or whether after development of 
germinal  centers and  organ redistribution of antigen  the  aggregated  antigen 
localized directly through the Fc fragment. Brown et al. (38) previously demon- 
strated that aggregated human gamma globulin, but not the monomeric form, 
rapidly localized in  the  germinal  centers  of the  lymph  nodes  in  a  dendritic 
pattern after intradermal injection into guinea pigs. The failure of succeeding 
peaks in the secondary response may be related to the more rapid disappearance 
of antigen (39). 
The PFC to HuIgG which appear in the peripheral blood apparently originate from 
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identical kinetic pattern  observed in cells from the blood and spleen are consistent 
with an exit of cells from the spleen into the blood. Strober (42) has obtained evidence 
for a qualitative change in the B cells after stimulation which allows them to migrate. 
He observed that thoracic duct cells from primed donors were capable of responding 
to  antigen  in  an  irradiated  recipient  after  passage  through  an  intermediate  host, 
while similarly passed normal thoracic duct cells were not able to respond, even though 
capable of responding if not passed. The differences  in the ability of the normal and 
primed passed  cells  to respond were attributed  to a  change at  the B-cell level,  in 
which the primed  B2 cell became capable of recirculating,  while  the virgin B1 cell 
could not. In the present situation,  the ability of the stimulated B~ cell to enter the 
circulation may be dependent on the loss of receptor sites during the process of differ- 
entiation,  thus freeing it from the antigenic  stimulus.  Depending  on the degree of 
stimulation,  the B2 cell  may either  differentiate  further into a  PFC,  or regenerate 
receptors and return  to the antigen deposits in the spleen  (or other organs)  where, 
after a latent period, it can be stimulated to differentiate further. Retention of spe- 
cifically sensitized cells from the circulation in lymphoid tissue containing the specific 
antigen has been shown by Ford (43) and Durkin and Thorbecke (44).  Migration of 
stimulated  cells  has also been observed by Cannon and  Wissler  (45),  who  demon- 
strated  [~H]thymidine-labeled  cells  in  the  blood  of  spleen-shielded,  irradiated  rats 
after antigen stimulation.  Unfortunately, the specificity of the cell in the  blood was 
not determined. Of course, not all cells stimulated by antigen and developing into B2 
cells  leave the spleen,  since more PFC are usually found in the spleen than in the 
peripheral blood. Other factors obviously play a role in whether a B~ cell leaves the 
spleen or develops into either plasma or memory cells within the spleen,  e.g., logistics 
of the cell, effectiveness  of antigenic stimulus, available space in the spleen,  and pos- 
sibly the inherent ability of each B~ cell to migrate. 
A  similar  phenomenon has  been observed  in  the  cellular  responsiveness  of 
rabbits  to rabbit  thyroglobulin after immunization with aqueous preparations 
of bovine thyroglobulin  (46). A  major peak of PFC appeared in the spleen 25 
days after a  series of injections of bovine thyroglobulin was initiated  and was 
directed  mainly against  those  determinants  specific for bovine thyroglobulin. 
7-8 days later,  PFC in the thyroid gland reached a peak, and these, in contrast 
to the early splenic PFC, were specific for only those determinants  on bovine 
thyroglobulin  shared  with  rabbit  thyroglobulin.  Thus,  it  would  appear  that 
rabbit  thyroglobulin  deposited  in  the  injured  gland was able  to  sequester  B2 
ceils  sensitized  to determinants  for rabbit  thyroglobulin,  and after  an appro- 
priate latent period possibly regulated by G1,  stimulated  the cells to produce 
antibody to rabbit thyroglobulin. 
SUMIVIARY 
After  a  single  intravenous  injection  of  rabbits  with  aggregated  HuIgG, 
IgM- and IgG-plaque-forming cells  (PFC)  in both the spleens  and peripheral 
blood of rabbits peaked 5, 13, and 21 days after injection, while almost no PFC 
could be detected on days 8 and  16. The available  data suggest that the sec- 
ondary peaks of PFC  (days  13  and 21)  resulted  from stimulation  of memory 1440  CYCLICAL  APPEARANCE  OF  ANTIBODY-PRODUCING  CELLS 
cells  by persisting  antigen  that was  localized in  the  germinal  centers  in  the 
spleen.  No such persistence of antigen occurred in the lymph nodes, and these 
lymphoid tissues did not exhibit secondary peaks of PFC. 
The identical kinetic patterns for IgM- and IgG-PFC indicate that the major 
portion of IgG-PFC did not result from IgM-secreting cells  switching to IgG 
synthesis and secretion. 
The present data suggest that the antibody produced and present at the site 
of interaction between committed cells and antigen is responsible for the regula- 
tion of antibody synthesis  to persisting  antigens.  Possible  cellular  events in- 
volveJ  in  both  the  regulation  and  an  apparent  synchronous appearance  of 
antibody producing cells in the spleens of rabbits were presented. 
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